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S U M M A R Y 
The Montenegro skin test is widely used as a diagnostic method for American 
cutaneous leishmaniasis ( A C L ) but little is known about the histological changes 
that occur in the skin after administration of the antigen. This report is based on 
histological studies of biopsied material obtained, from inoculation sites, 48 hours 
after individuals had been given intradermal injections with a standardized 
Montenegro antigen. The material examined was obtained from four distinctly 
different test groups: naturally infected patients with parasitologically proved A C L 
and with positive Montenegro's reaction; individuals without previous history of 
A C L and not previously tested with Montenegro antigen; participants in ant i-ACL 
vaccine trials who developed positive reactions to Montenegro antigen after 
vaccination; other participants in vaccine trials who had negative Montenegro 
responses after vaccination or had served as controls in the trials. The histological 
pictures of each group are described and discussed. Histologically, the reactions of 
vaccinated individuals were indistinguishable from those with naturally acquired 
infections. 
K E Y W O R D S : American Cutaneous leishmaniasis; Montenegro skin test; Histology 
of skin changes 
I N T R O D U C T I O N 
M O N T E N E G R O (1926) developed a skin 
test, using phenolized cultured promastigotes 
of Leishmania as antigen, to facilitate the 
diagnosis of American cutaneous leishmaniasis 
( A C L ) . The subsequent studies of S A L L E S 
GOMES (1939) showed that Montenegro 
antigen provoked a delayed hypersensitivity 
reaction in individuals with A C L . He also 
recorded that lesions tended to decrease in size 
after patients had been skin tested with the 
antigen and suggested that a modification of 
the Montenegro test could provide the basis of 
a prophyllactic vaccine against A C L . A crude 
vaccine against A C L was developed and field 
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tested in the State of São Paulo about 50 years 
ago (PESSOA & P E S T A N A , 1939; P E S S O A , 
1941a,b). In the São Paulo trials, the efficacy 
of the vaccine was assessed by statistical 
comparison to the incidence of infection in 
vaccinated and unvaccinated groups. 
The promising results obtained in the São 
Paulo studies were ignored for 34 years until 
M A Y R I N K et. al. (1979) developed a 
polyvalent killed promastigote vaccine and field 
tested it in a district of the município of 
Caratinga, State of Minas Gerais. The field 
trial in Caratinga was inconclusive because 
A C L disappeared from the study area during 
the period that observations were made. An 
important discovery in the Caratinga trials was 
the fact that a high proportion of vaccinated 
individuals showed changes in their responses 
to Montenegro antigen. The results suggested 
that the skin test could provide a means for 
assessing the degree of protection that 
developed from vaccination. 
Emergency use of the experimental vaccine in 
the State of Espírito Santo ( M A Y R I N K et. al., 
1985) revealed a significant level of protection 
amongst individuals who became Montenegro 
positive after vaccination. Responses to 
Montenegro antigen were later used in field 
trials of the experimental vaccine conducted 
amongst 18-year-old army conscripts under-
going jungle training in the vicinity of Manaus, 
State of Amazonas ( M A Y R I N K et al., 1986; 
A N T U N E S et al., 1986). The Manaus trials 
showed that about 70% of vaccinated 
individuals were protected against A C L . 
Although the Montenegro skin test is of 
proven value in the diagnosis of A C L and 
seems to be of utility in assessing vaccine 
prophyllaxis, little is known about the 
histological changes that occur in the skin after 
intradermal injection of the antigen. Herein, we 
record histological changes induced by 
administration of Montenegro antigen to four 
different groups of individuals. 
M A T E R I A L S A N D M E T H O D S 
Test groups 
Participants in the study were volunteers who 
gave written consent. 
Group I: Nine patients with A C L were 
examined at the S U C A M clinic Caratinga, 
Minas Gerais. A C L was diagnosed parasito-
logically and all had positive Montenegro's 
reaction. This constitutes the positive control 
group. 
Group I I : Five individuals had no history of 
A C L , had not been participants in trials of 
the experimental vaccine, and had not 
previously been tested with Montenegro 
antigen. This constitutes the negative control 
group. 
Group I I I : It consisted of nine 18-year-old 
army conscripts in Manaus who were Monte-
negro negative before vaccination and had 
positive reactions to the antigen 35 days after 
receiving the second (last) dose of vaccine. 
Group IV : Four army conscripts who par-
ticipated in the Manaus trials formed this 
group. A l l were initially Montenegro 
negative. Two were still negative 35 days 
after receiving the second dose of vaccine. 
The other two were Montenegro negative 
after receiving the placebo. 
Montenegro antigen 
The antigen was prepared and used in the 
manner described by M E L O et al. (1977), and 
was composed by pooling promastigotes of 
four stocks: I F L A / B R / 6 7 / P H 8 (Leishmania 
amazonensis); MHOM/BR/70/M1176 ( L . 
guyanensis); M H O M / B R / 7 5 / M 2 9 0 3 ( L . 
braz i l iens is) ; M H OM / B R / 6 0 / B H 6 ( L . 
mexicana). The antigen contained 40 meg 
N/ml, with 10 meg N/ml of each stock, 
obtained by sonicating promastigotes. 
Vaccine 
This was prepared by the methods described 
by M A Y R I N K et al. (1979) and contained 
pooled promastigotes of five stocks: 
MHOM/BR/70/M1176, isolated from a case 
of cutaneous leishmaniasis in the State oi Pará: 
M H O M / B R / 6 0 / B H 6 , isolated from a case of 
muco-cutaneous leishmaniasis in the State of 
Ceará: MHOM/BR/71 /BH49 , isolated from a 
case of dermal leishmaniasis in the State of 
Goiás: I F L A / B R / 6 7 / P H 8 , isolated from a 
naturally infected sand fly captured in the State 
of Pará: M H O M / B R / 7 3 / B H 121 isolated from 
a case of multiple dermal lesions, the patient 
living in the Rio Doce Valley of Minas Gerais. 
Each stock was cultured separatedly in L I T 
medium ( C A M A R G O , 1953) and harvested 
after seven days and pooled. 
In those individuals who were vaccinated, a 
freshly prepared vaccine containing 240 Hg/uil 
of nitrogen was given in two doses, each of 1.5 
ml, given with an interval of seven days. Both 
doses were delivered slowly by deep 
in! ramuscular in feet ion. 
Histological studies 
Biopsies were taken when reading reactions 
to Montenegro antigen 48 hours after it has 
been administered intradermically. Skin 
fragments were fixed in 10% formalin 
(buffered to pH 7.2), embedded in paraffin 
wax, sectioned at 5 ^m, and stained with 
haemaloxylin and eosin. 
R E S U L T S 
The following histological patterns were 
recorded in the four groups: 
Group I (Fig. 1). There were multiple foci of 
chronic inflammatory reactions of moderate 
intensity in the superficial and deep reticulate 
dermis. The exudate was almost entirely 
composed of mononuclear cells, with a few 
interspersed granulocytes. No giant Langhans 
cells were seen and there were no signs of gra­
nuloma formation. In one of the biopsies, 
there was a more pronounced reaction 
around sweat glands. 
f i g . 1 — Histological section of a positive Montenegro 
.'eaclion in a patient with natural ly-acquired A C L (Group I) 
< \ 640). 
Group I I (Fig. 2). A few sparsely distributed 
mononuclear cells were seen in the dermis. 
F i g . 2 — Histological section of a negative Montenegro 
reaction in a healthy individual not previously tested with 
the antigen (Group I I ) ( X 640). 
Group I I I (Fig. 3). There were multiple 
inflammatory perivascular and perianexial 
foci in the superficial and deep reticulate 
dermis, with some extensive foci and others 
confluent with each other. The exudate was 
almost exclusively composed of mononuclear 
cells but with scanty interspersed granulo­
cytes. No giant Langhans cells were seen. 
Collagen fibres were normal, oedema was 
slight, and the epidermis was normal. 
F i g . 3 — Histo logical section of a positive Montenegro 
reaction in a vaccinated individual (Group I I I ) ( X 640). 
Group I V (Figs. 4 & 5). Biopsies from the 
two vaccinated individuals who remain 
Montenegro negative were histologically 
similar to biopsies obtained from two 
members of the placebo group. In each of the 
four biopsies, there were perivascular and 
perianexial aggregations of mononuclear 
cells. 
F ig . 4 — Histological section o f a negative Montenegro 
reaction in an individual who received a placebo in a vacci ­
ne trial (Group I V ) ( X 640). 
f i g . 5 — Histological section of a negative Montenegro 
reaction in a vaccinated individual with an unchanged res­
ponse to the antigen (Group I V ) ( X 640). 
D I S C U S S I O N 
D H A L I W A L & L I E W (1987) distinguished 
between the tubercul in delayed-type 
hypersensitivity reaction and the earlier and 
more transient Jones-Mote response. The 
former is characterized histologically by 
infiltration of mononuclear cells at the site of 
antigen administration whereas there is an 
aggregation of basophils in the Jones-Mote 
reaction. Differentiation between these two 
types of delayed-type hypersensitivity is of 
importance in understanding the various 
immunological processes involved in cutaneous 
leishmaniasis. 
In experiments with B A L B mice and. L. 
major, D H A L I W A L et al. (1985) found that 
immunization, by subcutaneous or intradermal 
routes, with formaldehyde killed promastigotes 
did not protect the mice when challenged. The 
immunized hosts displayed a heightened 
susceptibility to infection in comparison with 
nonirnmunized, normal mice. These findings 
were explained by the later investigations of 
D H A L I W A L & L I E W (1987) and L I E W & 
D H A L I W A L (1987) who incorporated into 
their studies histological changes that occur at 
the site of inoculation of a test antigen. In 
material taken at the peak time for observing 
delayed-type hypersensitivity, it was found that 
reactions were of the Jones-Mote type, with 
scant mononuclear infiltration. In the B A L B 
mouse/ L . major model, immunization with 
killed promastigotes did not afford protection 
but, in fact, created a situation in which 
possible target cells for the parasites were 
aggregated. 
The present histological studies on the effects 
of Montenegro antigen in the dermis of human 
subjects gave results that differed markedly 
from the experimental observations already 
cited. It would be premature to attempt to 
explain the conflicting information: but factors 
such as the methods used in- preparing the 
immunizing agent, and/or the test antigen, 
and/or the administration of both, and/or the 
host/parasite combination studied, either 
individually or in various combinations, could 
explain the differences. 
Clinical experience with Montenegro antigen 
as a diagnostic tool for A C L , together with 
field experience in assessing the efficacy of an 
ant i -ACL vaccine, were the main reasons for 
obtaining biopsies 48 hours after giving the test 
antigen. Biopsies were, therefore, obtained at a 
time equivalent to the material studied by 
D H A L I W A L & L I E W (1987) and L I E W & 
D H A L I W A L (1987). 
Apart from the material from individuals in 
group I I (negative controls with minimal 
inflammatory reactions) the histological 
pictures in biopsies from the other three groups 
were qualitatively similar. There were no signs 
of a Jones-Mote type of reaction; the responses 
were of a tuberculin type and, therefore, 
indicative that protective processes were 
operative. 
Biopsies from groups I and I I I could not be 
distinguished histologically in double blind 
tests. On this basis, it would seem that 
vaccination, when followed by clear cut 
changes in response to Montenegro antigen, 
mimics the cellular immunological alterations 
that take place in naturally acquired A C L . 
These histological data do not pi ove thai a 
vaccinated individual with a convened 
Montenegro reaction is protected against A C L 
infection but merely that such an individual 
could be in an heightened immunological 
condition to resist against the parasites. 
Whether or not a vaccinated individual is, 
indeed, protected against infection, the 
histological similarities between groups 1 and 
I I I suggest that Montenegro testing provides 
the simplest and least expensive field method 
for assessing the effectiveness of an anti-ACL 
vaccine. However, it must be emphasized thai a 
change in response to Montenegro antigen after 
vaccination does not provide firm evidence thai 
an individual is protected against A C L . 
Histologically, the group IV biopsies were 
qualitatively similar to those of groups 1 and i l l 
but quantitatively less intense. Such a situation 
is understandable for the two vaccinated 
individuals who remained Montenegro 
negative. It can be supposed that some degree 
of immunological stimulation oeurrcd in these 
two but was not revealed by the skin test. The 
inflammatory reaction observed in the other 
two, who were not vaccinated but received the 
placebo, has three possible explanations. The 
two soldiers, continuing their jungle training in 
an A C L endemic area, were presumably 
exposed to the bites of sand flies naturally 
infected with Leishmania. Inoculation, by 
biting sand flies, of small numbers of infective 
forms or, even, non-infective stages of 
Leishmania might have been sufficient stimulus 
for the observed immunohistological changes. 
Such changes, however, could have been 
induced merely by the two Montenegro skin 
tests that the two soldiers of the placebo group 
underwent. In the present instance, both of the 
suggested stimuli, combined, might have 
induced the histological changes. 
The results presented herein are of relevance 
to the planning and assessment of field trials of 
potential vaccines against infection by 
Leishmania. The fact that Montenegro antigen, 
by itself, might initiate immunohistological 
changes is not surprizing because the antigen, 
like the vaccine used by M A Y R I N K et al. 
(1978, 1985, 1986) and A N T U N E S et al. (1986), 
is prepared from killed promastigotes. Indeed, 
it was the regression of leishmanial lesions 
following skin testing with Montenegro antigen 
( S A L L E S GOMES, 1939) that led to the 
development of an anti-ACL vaccine ( P E S S O A 
& P E S T A N A , 1940; P E S S O A , 1941a,b). The 
possibility that Montenegro antigen might 
stimulate immunological changes does not 
invalidate the use of this skin test in evaluating 
vaccines in the field. Although similar 
immunohistological changes were recorded in 
the skin of all individuals in group IV , all four 
were considered to be Montenegro negative 
when biopsies were obtained. 
However, the results show the necessity to 
exclude from vaccine field trials those 
individuals who have initial Montenegro 
positive reactions but have no history of 
disease. Because vaccine field trials have to be 
carried out in endemic areas, it must be 
assumed that a certain proportion of the 
resident population are already immune to 
infection as a result of exposure to bites of 
naturally infected sand flies but receiving 
insufficient parasites to induce lesion 
formation. 
R E S U M O 
Histologia da reação de Montenegro no 
homem após vacinação contra Leishmaniose 
Tegumentar Americana 
Foi realizado o estudo histológico do mate-
rial obtido nas biópsias do local de inoculação 
do antígeno para teste de Montenegro (T.M.) 
nos seguintes grupos de indivíduos: I) Seis pa-
cientes com leishmaniose cutânea comprovados 
parasitologicamente, com Montenegro positi-
vo; I I) Cinco indivíduos normais, não residen-
tes em zona endêmica, com Montenegro negati-
vo; I I I ) Nove soldados participantes de ensaios 
clínicos com vacina ant i-LTA — M A Y R I N K e 
cols. 1979 e que tiveram o TM positivo 35 dias 
após vacinação. IV) Um último grupo consti-
tuído de quatro soldados, também participan-
tes de ensaio clínico com a mesma vacina aci-
ma, dois vacinados que não mostraram TM po-
sitivo 35 dias após vacinação e dois que recebe-
ram placebo. 
As biópsias foram realizadas 48 hs após a 
inoculação do antígeno. O material foi fixado 
em formol à 10% (pH 7.2). 
Histologicamente, excetivando o grupo I I 
(controle negativo), os grupos I-I1I-IV mostra-
ram diferenças quantitativas no infiltrado mo-
nonuclear. Os quadros histológicos de cada 
grupo são descritos e discutidos. 
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